ORIGINAL RESEARCH
Published on 07 Jan 2025
SECTM1 acts as an immune-related biomarker of poor Prognosis and Promotes Cancer Progression by Modulating M2 macrophage polarization in esophageal squamous cell carcinoma
doi 10.3389/fimmu.2025.1507227
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of Cancer
Immune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of Cancer
205
Total downloads
1,571
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 06 Jan 2025
The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis
doi 10.3389/fimmu.2024.1511866
- 249 views
ORIGINAL RESEARCH
Published on 03 Jan 2025
Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer:A retrospective study
doi 10.3389/fonc.2025.1470445
ORIGINAL RESEARCH
Published on 17 Dec 2024
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
doi 10.3389/fonc.2024.1510278
- 533 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 1,571Topic views
- 814Article views
- 205Article downloads